ERVW-1 and renal carcinoma: Recently, Skandorff and colleagues (107) targeted HERV-W (syncytin-1) by evaluating vaccines encoding either the nonmutated or mutated envelope ISD in a murine renal carcinoma model genetically modified to express HERV-W Env.